Meeting
2020 Gastrointestinal Cancers Symposium
Feasibility and clinical impact of routine molecular testing of gastrointestinal (GI) cancers at a tertiary center with a multigene, next generation sequencing (NGS) panel.
Authors
Giacomo Bregni
Institut Jules Bordet-Université Libre de Bruxelles (ULB), Brussels, Belgium
Giacomo Bregni , Tiberio Sticca , Tugba Akin Telli , Silvia Camera , Ligia Ioana Craciun , Leila Shaza , Amélie Deleruelle , Maëlle Anciaux , Godelieve Machiels , Amélie Deleporte , Caroline Vandeputte , Pieter Demetter , Denis Larsimont , Alain Hendlisz , Francesco Sclafani
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Anal and Colorectal Cancer
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 216)
Abstract #
216
Poster Bd #
K16
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Molecular profiling of early-stage colorectal cancer (CRC) using targeted next generation sequencing (NGS) to predict signatures of recurrence.
First Author: Michael C. Burns
Poster
2014 Gastrointestinal Cancers Symposium
Molecular profiling of patients (pts) with advanced colorectal cancer (CRC): Princess Margaret Cancer Centre experience.
First Author: Joanne W. Chiu
First Author: Sandra Algaze
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A plasma-based analysis and genomic landscape of patients with high tumor mutational burden (TMB-H), microsatellite stable (MSS) colorectal cancer (CRC).
First Author: Anwaar Saeed